| 000 | 01771 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517205840.0 | ||
| 264 | 0 | _c20190611 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1872-7980 | ||
| 024 | 7 |
_a10.1016/j.canlet.2018.03.026 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan Heetvelde, Mattias | |
| 245 | 0 | 0 |
_aAccurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits. _h[electronic resource] |
| 260 |
_bCancer letters _c07 2018 |
||
| 300 |
_a125-133 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBRCA1 Protein _xgenetics |
| 650 | 0 | 4 |
_aBRCA2 Protein _xgenetics |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDNA Copy Number Variations |
| 650 | 0 | 4 | _aDNA Methylation |
| 650 | 0 | 4 | _aEpigenesis, Genetic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGerm-Line Mutation |
| 650 | 0 | 4 |
_aHereditary Breast and Ovarian Cancer Syndrome _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLoss of Heterozygosity |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aSequence Analysis, DNA _xmethods |
| 700 | 1 | _aVan Bockstal, Mieke | |
| 700 | 1 | _aPoppe, Bruce | |
| 700 | 1 | _aLambein, Kathleen | |
| 700 | 1 | _aRosseel, Toon | |
| 700 | 1 | _aAtanesyan, Lilit | |
| 700 | 1 | _aDeforce, Dieter | |
| 700 | 1 | _aVan Den Berghe, Ivo | |
| 700 | 1 | _aDe Leeneer, Kim | |
| 700 | 1 | _aVan Dorpe, Jo | |
| 700 | 1 | _aVral, Anne | |
| 700 | 1 | _aClaes, Kathleen B M | |
| 773 | 0 |
_tCancer letters _gvol. 425 _gp. 125-133 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.canlet.2018.03.026 _zAvailable from publisher's website |
| 999 |
_c28219691 _d28219691 |
||